Activated ras. Yet another player in melanoma?

No abstract is available for this paper.

• Publication year

  1996

• Venue

  American Journal of Pathology

• Publication date

  1996-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8780377PMCID PMC1865164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Retinoblastoma Protein and Cell Cycle Control Review

  2004cited by this paper
• Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.

  1996cited by this paper
• Carcinogenesis in human skin grafted to SCID mice.

  1996cited by this paper
• Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer.

  1996cited by this paper
• The murine N-ras gene is not essential for growth and development.

  1995cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors.

  1995cited by this paper
• Hyperpigmentation and melanocytic hyperplasia in transgenic mice expressing the human T24 HA‐ras gene regulated by a mouse tyrosinase promoter

  1995cited by this paper
• Role of the cyclin-dependent kinase inhibitors in the development of cancer.

  1995cited by this paper
• Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma.

  1995cited by this paper
• Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes.

  1995cited by this paper
• Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma.

  1995cited by this paper
• Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma

  1995cited by this paper
• p21ras as a Common Signaling Target of Reactive Free Radicals and Cellular Redox Stress (*)

  1995cited by this paper
• Ras‐effector interactions, the problem of specificity

  1995cited by this paper
• Regulation of Ras-mediated signalling: more than one way to skin a cat.

  1995cited by this paper
• Determination of the gene order of the three loci CD2, NGFB, and NRAS at human chromosome band 1p13 and refinement of their localisation at the subband level by fluorescence in situ hybridisation.

  1995cited by this paper
• p21 Ras as a governor of global gene expression.

  1994cited by this paper
• Point mutations in the N‐ras oncogene in malignant melanoma and congenital naevi

  1994cited by this paper
• Melanoma metastases from patients with hereditary cutaneous malignant melanoma contain a high frequency of N-ras activating mutations

  1994cited by this paper
• Ras mutations in human melanoma: a marker of malignant progression.

  1994cited by this paper
• A single P1 clone bearing three genes from human chromosome 11p15.5: HRC1, HRAS1, and RNH.

  1994cited by this paper
• DP and E2F proteins: coordinating transcription with cell cycle progression.

  1994cited by this paper
• Development of transgenic mouse models of skin carcinogenesis: potential applications.

  1994cited by this paper
• UV INDUCTION OF CYCLOBUTANE THYMINE DIMERS IN THE DNA OF CULTURED MELANOCYTES FROM FORESKIN, COMMON MELANOCYTIC NEVI and DYSPLASTIC NEVI

  1994cited by this paper
• Investigation of the role of the ras protooncogene point mutation in human uveal melanomas.

  1993cited by this paper
• Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype.

  1992cited by this paper
• Malignant melanoma in transgenic mice.

  1991cited by this paper
• Lack of evidence of Ki‐ras codon 12 mutations in melanocytic lesions

  1991cited by this paper
• Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene.

  1991cited by this paper
• PCR assay for a polymorphic TaqI site in the human K-ras-2 gene on chromosome 12p (KRAS2).

  1991cited by this paper
• Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene.

  1990cited by this paper
• Transgenic mice carrying the mouse mammary tumor virus ras fusion gene: distinct effects in various tissues

  1989cited by this paper
• ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development.

  1989cited by this paper
• Differential expression of ras oncogene products among the types of human melanomas and melanocytic nevi.

  1989cited by this paper
• N-ras mutations in human cutaneous melanoma from sun-exposed body sites

  1989cited by this paper
• Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.

  1989cited by this paper
• Animal model for ultraviolet radiation-induced melanoma: platyfish-swordtail hybrid.

  1989cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• ULTRAVIOLET RADIATION ‐ INDUCED MALIGNANT MELANOMA IN Monodelphis domestica

  1989cited by this paper
• Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay.

  1988cited by this paper
• Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice.

  1987cited by this paper
• Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice.

  1987cited by this paper
• Structure of the human and murine R-ras genes, novel genes closely related to ras proto-oncogenes.

  1987cited by this paper
• Evidence against Ha-ras-1 involvement in sporadic and familial melanoma

  1987cited by this paper
• Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.

  1987cited by this paper

• Heparan sulfate proteoglycans and heparin regulate melanoma cell functions.

  2014cites this paper
• Skin Cancer Prevention

  2014cites this paper
• GRM1, A POTENTIAL TARGET FOR HUMAN MELANOMA

  2013cites this paper
• Ras‐induced melanoma transformation is associated with the proteasomal degradation of the transcriptional repressor ICER

  2013cites this paper
• Reviewing the somatic genetics of melanoma: from current to future analytical approaches

  2012cites this paper
• Whole genome and exome sequencing of melanoma: a step toward personalized targeted therapy.

  2012cites this paper
• Malignant Transformation of Melanocytic Nevi

  2012cites this paper
• PUBLIC HEALTH AND THE EYE

  2012cites this paper
• Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth

  2011cites this paper
• Preclinical Study of PI3K and BRAF Inhibitors in Malignant Melanoma

  2010cites this paper
• Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7--challenging the concept of dysplastic nevi as precursor lesions?

  2010cites this paper
• Tumor suppression by ARF: Gatekeeper and caretaker

  2010cites this paper
• Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation

  2010cites this paper
• Genetic Interaction Between NRAS and BRAF Mutations and PTEN / MMAC 1 Inactivation in Melanoma

  2010cites this paper
• The role of mammalian coronins in development and disease.

  2008cites this paper
• Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation

  2008cites this paper
• BRAF and NRAS mutations in melanoma and melanocytic nevi

  2006cites this paper
• BRAF somatic mutations in malignant melanoma and melanocytic naevi

  2006cites this paper
• Bases genéticas del cáncer de piel

  2006cites this paper
• Clinical pathologic challenge

  2005cites this paper
• Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases

  2005cites this paper
• Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi

  2005cites this paper
• Integrin signaling in malignant melanoma

  2005cites this paper
• Role of Epidermal Growth Factor Receptor Signaling in RAS-Driven Melanoma

  2005cites this paper
• HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1

  2005cites this paper
• Role of nuclear factor-kappa B in melanoma.

  2005cites this paper
• Preponderance of the oncogenic V599E and V599K mutations in the B-raf kinase domain is enhanced in melanoma lymph node metastases

  2005cites this paper
• Role of nuclear factor-κ B in melanoma

  2005cites this paper
• Sunlight exposure and pathogenesis of uveal melanoma.

  2004cites this paper
• Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.

  2004cites this paper
• Melanoma Cell Autonomous Growth: The Rb/E2F Pathway

  2004cites this paper
• The T1796A mutation of the BRAF gene is absent in Spitz nevi

  2004cites this paper
• The longer your telomeres, the larger your nevus?

  2003cites this paper
• A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

  2003cites this paper
• Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo

  2003cites this paper
• BRAF as a potential therapeutic target in melanoma and other malignancies.

  2003cites this paper
• Mutational analysis of N-ras , p 53 , CDKN 2 A ( p 16 INK 4 a ) , p 14 ARF , CDK 4 , and MC 1 R genes in human dysplastic melanocytic naevi

  2003cites this paper
• The INK4a/ARF locus and melanoma

  2003cites this paper
• Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer

  2003cites this paper
• Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model

  2003cites this paper
• Advances in Brief Constitutive Mitogen-activated Protein Kinase Activation in Melanoma Is Mediated by Both BRAF Mutations and Autocrine Growth Factor Stimulation 1

  2003cites this paper
• Mutational analysis of N-ras, p53, CDKN2A (p16INK4a), p14ARF, CDK4, and MC1R genes in human dysplastic melanocytic naevi

  2003cites this paper
• Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.

  2003cites this paper
• Death receptors and melanoma resistance to apoptosis

  2003cites this paper
• Clinical and Laboratory Investigations Tyrosine phosphate in melanoma progression

  2003cites this paper
• Pharmacogenetic candidate genes for melanoma.

  2003cites this paper
• Cellular and Molecular Biology of Human Melanoma

  2002cites this paper
• A genome-based strategy uncovers frequent BRAF mutations in melanoma.

  2002cites this paper
• Genomische Analyse von Melanomen und melanozytären Nävi

  2002cites this paper
• Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM‐CSF as adjuvant

  2001cites this paper
• Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features.

  2000cites this paper
• Animal models of melanoma: recent advances and future prospects.

  2000cites this paper
• Protein tyrosine kinases in malignant melanoma.

  2000cites this paper
• Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.

  2000cites this paper
• The molecular basis of canine melanoma: pathogenesis and trends in diagnosis and therapy.

  1999cites this paper
• Pathogenese des malignen Melanoms Molekularbiologische Aspekte

  1999cites this paper
• Mutational analysis of the N-ras,p53,p16INK4a ,CDK4, and MC1R genes in human congenital melanocytic naevi

  1999cites this paper
• [Pathogenesis of malignant melanoma. Molecular biology aspect].

  1999cites this paper
• RAS and leukemia: from basic mechanisms to gene-directed therapy.

  1999cites this paper
• Induction of melanoma in TPras transgenic mice.

  1999cites this paper
• Ultraviolet radiation and malignant melanoma.

  1998cites this paper
• Pigmented uveal tumours in a transgenic mouse model

  1998cites this paper
• Gene therapy for melanoma in humans.

  1998cites this paper
• Tumorgenetik des malignen Melanoms

  1998cites this paper